13-110161176-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.4640+16G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 1,610,684 control chromosomes in the GnomAD database, including 21,833 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1880 hom., cov: 33)
Exomes 𝑓: 0.16 ( 19953 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0310

Publications

13 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 13-110161176-C-T is Benign according to our data. Variant chr13-110161176-C-T is described in ClinVar as Benign. ClinVar VariationId is 258256.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.31 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001845.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
NM_001845.6
MANE Select
c.4640+16G>A
intron
N/ANP_001836.3P02462-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
ENST00000375820.10
TSL:1 MANE Select
c.4640+16G>A
intron
N/AENSP00000364979.4P02462-1
COL4A1
ENST00000650424.2
c.4640+16G>A
intron
N/AENSP00000497477.2A0A3B3ISV3
COL4A1
ENST00000933608.1
c.4541+16G>A
intron
N/AENSP00000603667.1

Frequencies

GnomAD3 genomes
AF:
0.153
AC:
23223
AN:
152064
Hom.:
1881
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.117
Gnomad AMI
AF:
0.138
Gnomad AMR
AF:
0.189
Gnomad ASJ
AF:
0.155
Gnomad EAS
AF:
0.323
Gnomad SAS
AF:
0.192
Gnomad FIN
AF:
0.108
Gnomad MID
AF:
0.220
Gnomad NFE
AF:
0.156
Gnomad OTH
AF:
0.184
GnomAD2 exomes
AF:
0.166
AC:
41781
AN:
250984
AF XY:
0.166
show subpopulations
Gnomad AFR exome
AF:
0.118
Gnomad AMR exome
AF:
0.181
Gnomad ASJ exome
AF:
0.168
Gnomad EAS exome
AF:
0.303
Gnomad FIN exome
AF:
0.106
Gnomad NFE exome
AF:
0.155
Gnomad OTH exome
AF:
0.180
GnomAD4 exome
AF:
0.161
AC:
235388
AN:
1458502
Hom.:
19953
Cov.:
30
AF XY:
0.161
AC XY:
117161
AN XY:
725738
show subpopulations
African (AFR)
AF:
0.118
AC:
3953
AN:
33414
American (AMR)
AF:
0.180
AC:
8030
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.171
AC:
4467
AN:
26124
East Asian (EAS)
AF:
0.312
AC:
12361
AN:
39650
South Asian (SAS)
AF:
0.177
AC:
15257
AN:
86110
European-Finnish (FIN)
AF:
0.110
AC:
5891
AN:
53396
Middle Eastern (MID)
AF:
0.233
AC:
1318
AN:
5652
European-Non Finnish (NFE)
AF:
0.157
AC:
173725
AN:
1109230
Other (OTH)
AF:
0.172
AC:
10386
AN:
60244
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
9503
19007
28510
38014
47517
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6332
12664
18996
25328
31660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.153
AC:
23235
AN:
152182
Hom.:
1880
Cov.:
33
AF XY:
0.154
AC XY:
11438
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.117
AC:
4858
AN:
41518
American (AMR)
AF:
0.189
AC:
2892
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.155
AC:
537
AN:
3470
East Asian (EAS)
AF:
0.323
AC:
1666
AN:
5158
South Asian (SAS)
AF:
0.191
AC:
920
AN:
4828
European-Finnish (FIN)
AF:
0.108
AC:
1148
AN:
10600
Middle Eastern (MID)
AF:
0.216
AC:
63
AN:
292
European-Non Finnish (NFE)
AF:
0.156
AC:
10639
AN:
68010
Other (OTH)
AF:
0.183
AC:
386
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1033
2067
3100
4134
5167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
246
492
738
984
1230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.153
Hom.:
330
Bravo
AF:
0.158
Asia WGS
AF:
0.261
AC:
906
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
3
not specified (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.4
DANN
Benign
0.37
PhyloP100
0.031
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2275842; hg19: chr13-110813523; COSMIC: COSV65423059; COSMIC: COSV65423059; API